Violation Tracker Individual Record
Date:December 12, 2012
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Secondary Offense:consumer protection violation
Pfizer agreed to pay $42.9 million to settle multistate litigation alleging that it engaged in unlawful marketing of its drugs Zyvox and Lyrica, including the promotion of Lyrica for uses not approved by the Food and Drug Administration.
Level of Government:state
Action Type:agency action
Agency:Multistate Attorneys General Case
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:New York
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.